Human brain malformations, such as Miller±Dieker syndrome (MDS) or isolated lissencephaly sequence (ILS) may result from abnormal neuronal migration during brain development. MDS and ILS patients have a hemizygous deletion or mutation in the LIS1 gene (PAFAH1B1), therefore, the LIS1 encoded protein (Lis1) may play a role in neuronal migration. Lis1 is a subunit of a brain platelet-activating factor acetylhydrolase (PAFAH1B) where it forms a heterotrimeric complex with two hydrolase subunits, referred to as 29 kDa (PAFAH1B3) and 30 kDa (PAFAH1B2). In order to determine whether this heterotrimer is required for the developmental functions of PAFAH1B, we examined the binding properties of 29 and 30 kDa subunits to mutant Lis1 proteins. The results de®ned the critical regions of Lis1 for PAFAH1B complex formation and demonstrated that all human LIS1 mutations examined resulted in abolished or reduced capacity of Lis1 to interact with the 29 and 30 kDa subunits, suggesting that the PAFAH1B complex participates in the process of neuronal migration. q
Introduction
The mammalian brain develops through a process of highly organised neuronal migration. The adult cerebral cortex consists of six neuronal layers formed by aǹ inside-out' layering of post-mitotic neurons that have migrated from the ventricular zone (reviewed in Pearlman et al., 1998) . Some human syndromes that display cortical malformations are thought to arise from abnormal neuronal migration. These include isolated lissencephaly sequence (ILS) and Miller±Dieker syndrome (MDS), both of which are characterised by smooth brain surfaces and disorganised cortical layering . Patients with either syndrome present with profound mental retardation and seizures with MDS patients also having an abnormal craniofacial appearance. The gene responsible for the brain phenotype in ILS and MDS patients, LIS1, was identi®ed using informative deletions of 17p13.3 Reiner et al., 1993) and several point mutations (Lo Nigro et al., 1997) . These point mutations are all likely to be loss of function mutations since the phenotypes of patients with LIS1 point mutations are comparable to those patients that harbour LIS1 deletions. Correlation of the sites of mutation with the human phenotype, however, has failed to delineate a critical site in the Lis1 protein since all of the mutations led to brain malformations.
The LIS1 protein (Lis1) is highly conserved and differs by only one amino acid between humans and mice, by only three amino acids between human and bovine and shows 70% identity with Drosophila Lis1 (Hattori et al., 1994; Peterfy et al., 1994; Peterfy et al., 1998; Liu et al., 1999) . Strong expression of LIS1 occurs in neurons undergoing or preparing for migration in both the developing human and mouse brains (Reiner et al., 1995; Albrecht et al., 1996) . Homozygous null mice die soon after implantation suggesting an essential role in early embryonic development (Hirotsune et al., 1998) . Heterozygous mice display cortical, hippocampal and olfactory bulb disorganisation (Hirotsune et al., 1998) . In vitro cell migration assays and in vivo BrdU labelling experiments strongly support the notion that the phenotype observed in these heterozygote mice is the result of abnormal neuronal migration (Hirotsune et al., 1998) .
Lis1 is a component of the brain, intracellular plateletactivating factor acetylhydrolase complex, classi®ed as PAFAH1B (herein referred to as simply PAFAH), where it interacts with two enzymes, a 30 kDa protein (also known as PAFAH1B2) and a 29 kDa (or PAFAH1B3) protein (Hattori et al., 1994) . These enzymes inactivate PAF by removing the acetyl group at the sn-2 position. In vitro assays show that PAF analogues capable of inhibiting PAFAH activity decrease the migration of cerebellar granule cells on a laminin substrate Bix and Clark, 1998) , suggesting a link between PAF hydrolysis and neuronal migration. PAF exposure also causes neuronal cytoskeletal alterations in cultured hippocampal neurites, leading to growth cone collapse, neurite retraction and neurite varicosity formation (Clark et al., 1995) . These neurite shape changes are accompanied by rearrangement of microtubules and the retrograde movement of mitochondria, changes suggestive of the activation of a microtubulebased motor (McNeil et al., 1999) . The 29 and 30 kDa subunits are coexpressed with LIS1 in neuronal tissue during the time of migration (Albrecht et al., 1996) . In rats and mice it has been clearly demonstrated that there is a switch from Lis1-29-30 kDa containing complexes in the developing brain to complexes that consist of only Lis1 and the 30 kDa subunits in the adult brain (Albrecht et al., 1996; Manya et al., 1998) . The temporal expression pattern of the 29 kDa subunit correlates exactly with the timespan of neuronal migration (Manya et al., 1998) .
Lis1 belongs to a family of proteins containing the WD40 repeat motif (Neer et al., 1994) . Some WD40 proteins act as intracellular receptors linking functional machinery together and hence have been referred to as`scaffolding' proteins Kitagawa et al., 1999; Sidow et al., 1999) . The best-characterised member is the heterotrimeric transducin. The crystal structures of the bsubunit of transducin as a dimer with the G tg subunit, bound to the G ta subunit and in complex with its regulator, phosducin, have been solved (Wall et al., 1995; Gaudet et al., 1996; Lambright et al., 1996; Sondek et al., 1996) . The bsubunit of transducin has an N-terminal helix followed by a b -propeller structure formed by repeating units of b -sheets, each with four antiparallel strands, forming the`blades' . Lis1, like b -transducin, contains an N-terminal region and 7 WD40 repeat sequences. Limited proteolysis and sedimentation studies of Lis1 and several other WD40 proteins would suggest that all WD40-containing proteins form a circular, propeller-like structure (Garcia-Higuera et al., 1996) . Additionally, the crystal structure of the 29 kDa subunit of PAFAH shows striking similarities to the a -subunit of heterotrimeric G proteins (Ho et al., 1997) . Hence, the interactions of b -transducin provide a model for determining which sites may be important for protein-protein interactions for Lis1 with the 29 and 30 kDa subunits of PAFAH.
This study used a combination of human LIS1 mutations and site-directed mutations of amino acids found to be critical in the transducin heterotrimer to determine whether complex formation and neuronal migration phenotypes are linked. Speci®cally, site-directed mutagenesis was used to generate a series of LIS1 mutants. A yeast two-hybrid assay and GST-pull-downs were then employed to assess the binding capacity of the mutants to the 29 and 30 kDa PAFAH subunits. These data reveal that all the WD40 repeat units may be essential for PAFAH complex formation and that the second WD40 repeat unit may be particularly important for interaction of the 29 and 30 kDa subunits to Lis1. Hence these ®ndings reveal a correlation between PAFAH complex formation and neuronal migration, supporting a role for this complex in human brain development.
Results

Generation and expression of mutant Lis1 proteins
Mutations in LIS1 do not cluster around a particular region of the gene (Lo Nigro et al., 1997; Pilz et al., 1998; Fogli et al., 1999; Pilz et al., 1999) . We elected, therefore, to investigate a series of human mutations that corresponded to a range of lissencephaly phenotypes as summarised in Table  1 . This range of phenotypes is exempli®ed in Fig. 1 , which shows magnetic resonance imaging of the brains of a normal subject compared to four patients whose Lis1 mutations were investigated in this paper. Since the mouse and human Lis1 proteins are identical except for a single amino acid change, we used mouse Lis1 (mLis1) in these studies. In total, eight mutations of mLis1 were examined, six of which re¯ected mutations that had been described in human lissencephaly patients and two that altered residues shown to be important for the interaction of b -transducin with the G ta subunit and phosducin (see Section 1). Four of these mutations resulted in single amino acid changes, three in truncated proteins of varying lengths and one which removed only the N-terminus but left the seven WD40 repeats intact (Fig. 2) .
The mutant cDNA constructs were generated as described in Section 3 using mLis1pAS2 plasmid as the template. All constructs were sequenced using a total of six sequencing primers across the open reading frame to ensure that the expected mutations were present and that there were no errors incorporated by the polymerase. Each of the mutants and the wild-type mLis1pAS2 construct were transformed separately into the PJ69-4A strain of yeast. Nutritional selection (tryptophan dropout media) was used to isolate yeast colonies containing the plasmid of interest. Selected yeast colonies were cultured until mid-log phase then harvested for protein. Equivalent amounts of yeast cell lysate were separated via SDS±PAGE and Western-blotted onto PVDF membrane. Wild-type and mutant mLis1 proteins were detected by means of an antibody directed against the HA-epitope tag, which consists of nine amino acids directly N-terminal to mLis1 encoded for on the pAS2 vector. Fusion proteins of expected size were detected (Fig.  3) . Mutants mLis1D304 and mLis1DN consistently resulted in lower fusion protein yields for a given density of yeast culture although this did not seem to affect the ability to detect binding in a yeast two-hybrid assay as discussed below. The HA antibody recognised a number of non-speci®c yeast proteins, as determined by Western blotting lysate from non-transformed yeast cells (data not shown). The extra protein band at~48 kDa in the mLis1D144 lane was a consistent but unexplainable observation, perhaps due to a non-speci®c transcription/translation event. This protein, however, did not bind to the 29 or 30 kDa subunits, as discussed below.
Binding patterns of mLis1 mutants in the yeast twohybrid assay
A GAL4-based yeast two-hybrid assay was used to examine binding of the wild-type or mutant mLis1 to the 29 and 30 kDa proteins. The cDNAs encoding for the 29 and 30 kDa proteins were subcloned into the pACT2 vector, creating a fusion between the 29 or 30 kDa protein and the GAL4 activation domain. These constitute the`prey' constructs. The wild-type and mutant mLis1pAS2 constructs (bait constructs) were co-transformed with either the 29 kDa pACT2 or 30 kDa pACT2 construct into the PJ69-4A yeast strain. Co-transformation ef®ciency was monitored on selection media lacking both leucine (leu) and tryptophan (trp), since these amino acids are encoded for on the pACT2 and pAS2 vectors, respectively. The series of cotransformation controls is shown in Fig. 4 , panel A; growth on these plates indicates successful transformation of the bait and prey constructs.
The PJ69-4A yeast cell strain incorporates both a histidine (his) and an adenine (ade) reporter gene under the control of a GAL promoter. Hence, growth on media lacking histidine or adenine indicates that the two fusion proteins expressed in the yeast are capable of binding. Selection via the adenine reporter construct is the more stringent means for assessing protein-protein interactions (James et al., 1996) . The co- Fig. 1 . Magnetic resonance imaging of normal and lissencephalic brains. Axial scans of human brains from one normal subject and four of the patients whose mutations were investigated in this study. The Lis1 mutations correspond to the following patient identity numbers and grades of severity; Lis1D144 is patient number LP97-078, grade 2; Lis1D304 is patient LP97-021, grade 3; Lis1H149R is patient LP93-012, grade 3 and Lis1S169P is patient LP94-051, grade SBH. Grade 3 lissencephaly Pilz et al., 1998 transformed yeast strains shown in Fig. 4 , panel A were replated on triple dropout media (-leu, -trp, -his or ±leu, -trp, -ade) as shown in Fig. 4 panels B and C. These data are representative of several similar experiments all of which demonstrated the same patterns of growth. Fig. 4 , panels B and C show that wild-type mLis1 was capable of binding to both the 29 and 30 kDa proteins, as expected. Negative controls showed that the bait and prey proteins did not self activate the reporter genes when cotransformed with empty bait (pAS2) or prey (pACT2) vectors (Fig. 4) . Not shown in this ®gure are the pACT2 negative controls on histidine dropout media since they were consistently the same as shown here for the adenine dropout plates. The amino acids altered in mLis1S152W and mLis1V400W are analogous to the residues shown to be crucial for b -transducin binding to phosducin and G ta (Gaudet et al., 1996) . Both of these point mutations in mLis1 permitted binding of the 29 and 30 kDa PAFAH subunits (Fig. 4, panel B) . It should be noted, however, that when yeast were co-transformed with mLis1S152W and either prey construct they were unable to grow in the absence of adenine (Fig. 4, panel C) . Hence the proteinprotein interaction was suf®cient to allow growth on the less stringent histidine dropout plates but the binding seemed not strong enough to suf®ciently activate the adenine reporter gene. Similarly, mLis1DN showed altered binding to the 30 kDa protein compared to wild-type mLis1, since growth was permitted on the histidine but not the adenine selection plates. This mutation is similar but not identical to an alteration found in patient ILS-107 where the fourth exon had been deleted, leading to a partial loss of the N-terminal region of Lis1 (Fogli et al., 1999) . All other mutations examined lead to loss of binding of mLis1 to both the 29 and 30 kDa proteins. These mutations were all human mutations and included three truncated proteins (mLis1D386, mLis1D144, mLis1D304) and two point mutations both in the second WD40 repeat (mLis1H149R and mLis1S169P) (Fig. 2) .
Binding patterns of mLis1 mutants in GST-pull-down assays
To verify the results seen in the yeast two-hybrid system by another method, GST-pull-down experiments were performed. GST fusion proteins were generated with the 29 and 30 kDa subunits. Wild-type and mutant mLis1 was S-methionine using a transcription/translation protocol (Promega TNT system). The GST-29 kDa and GST-30 kDa proteins were incubated with the 35 S-labelled mLis1 proteins. Glutathione agarose was employed to isolate the GST-fusion and bound proteins, which were then separated by SDS±PAGE. The resultant gel was subjected to autoradiography to detect radiolabelled mLis1 proteins that had been bound to the GST-fusion proteins. GST alone served as a negative control (lane 2 Fig. 5, panels A and B ). An aliquot of the supernatant was also analysed to control for mLis1 expression (Fig. 5C ). Panel C shows that the level of protein expression and hence`input' protein was similar for the wild-type mLis1 and mutants tested. Fig. 5 represents several similar experiments that showed the same binding patterns.
As can be seen in Fig. 5 , panels A and B, mLis1 was pulled down with both the 29 and 30 kDa GST-fusion proteins. Similarly, the mLis1S152W, mLis1V400W and mLis1DN proteins bound to both fusion proteins. It was observed, however, that less mLis1S152W and mLis1DN bound to both fusion proteins than was apparent for the wild-type mLis1, despite similar levels of expression (Fig.  5, panel C) . These GST pull-down experiments would suggest that the mLis1DN mutant had reduced binding af®-nity to both the 29 and 30 kDa subunits although the yeast two-hybrid assay showed only a reduction in binding to the 30 kDa subunit. The reason for this discrepancy is not clear but may be due to the different N-terminal fusion moieties. All other Lis1 mutants tested failed to bind to either fusion protein. These results, therefore, mirrored the binding patterns observed using the yeast two-hybrid system.
Discussion
The molecular signalling pathways that direct neuronal migration are a current focus of studies into brain development since a number of genes responsible for disrupting this process have recently been identi®ed including the mouse reelin, mdab1, cdk5, p35, VLDL receptor and ApoE receptor 2 genes as well as human LIS1, DCX and FLN1 (Caviness and Sidman, 1973; Dobyns et al., 1993; Reiner et al., 1993; Ohshima et al., 1996; Chae et al., 1997; Howell et al., 1997; Lo Nigro et al., 1997; Sheldon et al., 1997; Ware et al., 1997; des Portes et al., 1998; Fox et al., 1998; Gilmore et al., 1998; Gleeson et al., 1998; D'Arcangelo et al., 1999; Hiesberger et al., 1999) . Mutants with a neuronal migration disorder include humans with lissencephaly owing to LIS1 deletions or mutations. Lis1 has been puri®ed from bovine brain extract as part of a heterotrimeric PAFAH complex (Hattori et al., 1994) but may have PAFAH-independent modes of action. We have used Lis1 mutations found in the patient population with lissencephaly in order to determine if there is a correlation between neuronal migration disorder and the ability of Lis1 to form a complex with the 29 and 30 kDa subunits. Furthermore, these data begin to identify the important binding domains in this member of the WD40 repeat family.
The results of the present study strongly suggest a role for the PAFAH complex in brain development. All human mutations examined compromised Lis1 binding to the remaining PAFAH subunits. The human mutations that removed the WD40 repeat regions led to total loss of binding to both the 29 kDa and the 30 kDa proteins. The truncating mutations, mLis1D386, mLis1D144 and mLis1D304 (Fig. 2) , demonstrated that all seven WD40 repeats may be necessary for binding of 29 and 30 kDa proteins to Lis1. Possibly all seven repeat structures must be present for the protein to assume its predicted, b -propeller structure . Indeed, biochemical analyses of Lis1 truncation mutants have shown that they are unable to form a globular structure (Garcia-Higuera et al., 1996) . It may be that these truncated proteins are not stably expressed in vivo since mutant proteins could not be detected in lymphoblastoid cell lysates derived from two patients harboring truncating mutations of Lis1 (Fogli et al., 1999) . Nevertheless, the truncating mutations examined in this study were expressed in vitro and in yeast cells and allowed us to conclude that all seven WD40 repeats of Lis1 may be necessary for formation of PAFAH complexes.
We predicted that the 29 and 30 kDa subunits of PAFAH may bind to Lis1 in the same fashion that phosducin and G ta bind to b-transducin, due to the structural similarities between the two WD40 proteins and between the 29 kDa protein and G a subunits Ho et al., 1997) . In b transducin, the 16th residue of each WD40 repeat contacts phosducin in six out of seven b -transducin repeats and contacts G ta in the ®rst ®ve repeats (Gaudet et al., 1996) . This particular residue has also been implicated by yeast genetics to be important for G a and G b g interaction (Whiteway et al., 1994) . The residue at position 34 of all seven WD40 repeats contacts phosducin by projecting outward from the top propeller surface (Gaudet et al., 1996) and interacts with G ta in repeats two and seven . It was logical, therefore, to predict these residues might also be important for Lis1 binding to the 29 and 30 kDa subunits. The amino acid at position 16 in the second WD40 repeat of Lis1 is a serine (residue 152) residue and at the 34th position of the seventh WD40 repeat is a valine (residue 400). Mutants mLis1S152W and mLis1V400W were attempts to replace these two amino acids with small side chains by tryptophan residues with a bulky side-chain with the aim of sterically hindering binding at these sites. Residue 400 of Lis1 may not be critical for 29 and 30 kDa interaction since this mutation did not affect binding. The altered serine in the second repeat probably is involved in Lis1 binding since mutating this amino acid markedly reduced the strength of binding, particularly to the 30 kDa protein in the yeast two-hybrid system.
The two human point mutations in the second WD40 repeat region (mLis1H149R and mLis1S169P) were also informative. These two missense mutations both resulted in Lis1 proteins that were incapable of binding to either the 29 or 30 kDa subunits. The histidine residue altered in mLis1H149R is conserved as the 13th amino acid in every one of the seven WD40 repeats for Lis1, suggesting that it may have an important structural role for the repeat unit. Interestingly, histidine is also conserved as the 13th amino acid in 584 out of 776 WD40 repeat regions aligned from 152 WD-repeat proteins (Smith et al., 1999) . Indeed, the crystal structure of b-transducin revealed that the 13th residue of each WD40 repeat is part of a structural triad that positions adjacent blades of the b -propeller . Given the b-transducin data and the high conservation of this residue, it is most likely that this histidine is an important structural residue and that conversion to arginine results in destabilisation of the second WD40 repeat unit. A study published during the drafting of this manuscript has also demonstrated that the Lis1H149R mutant cannot bind to the 29 or 30 kDa proteins (Manya et al., 1999) . This study used Sf9 expressed Lis1, 29 and 30 kDa proteins and assessed binding via column chromatography (Manya et al., 1999) . These data may underscore the importance of the second repeat unit of Lis1 for protein-protein interactions.
The second point mutation examined, mLis1S169P, also lies within the second WD40 repeat of Lis1. This mutation changes a serine residue to a proline and results in abolishment of Lis1 binding to both PAFAH subunits. This serine lies at position 33 of the second repeat unit but is also conserved at the same position in 417 out of 776 WDrepeats examined (Smith et al., 1999) . It precedes an aspartate that is absolutely conserved in all repeat units of Lis1 and in 670 out of 776 studied repeats (Smith et al., 1999) . This aspartate is known to be part of the structural triad previously mentioned. The serine residue may be important for the correct positioning of this structurally important aspartate. A recent study suggested that Lis1 might be regulated by phosphorylation of its serine residues (Sapir et al., 1999) . Perhaps the particular serine residue mutated in mLis1S169P is a target for phosphorylation and hence regulation of Lis1 functions. It is interesting that the only two point mutations found that led to a human brain phenotype are both in the second WD40 repeat suggesting that this repeat unit may be of particular importance for the interaction of the 29 and 30 kDa proteins with Lis1 and indirectly for neuronal migration.
The mLis1DN mutant was capable of binding to both the 29 and 30 kDa proteins, although the binding seemed to be less than that to wild-type Lis1. Nevertheless, these data indicate that the N-terminal region of Lis1 is not critical for binding to either 29 or 30 kDa proteins but may in¯uence the stability of these interactions. Earlier in vitro studies also demonstrated that Lis1 lacking its N-terminus was still capable of binding to a number of proteins with pleckstrin homology domains (Wang et al., 1995) . In line with these data, biochemical analyses have shown that a Lis1 protein lacking the N-terminal region is still able to form a globular protein (Garcia-Higuera et al., 1996) . Western blotting of ®broblast lysate, derived from a patient with an N-terminal Lis1 mutation, showed expression of the mutant Lis1 protein, evidencing its stability in vivo (Fogli et al., 1999) .
An obvious question is whether or not the strength of binding of the mutant Lis1 proteins to the 29 and 30 kDa proteins correlates with the severity of phenotype observed in the corresponding patients. Of the mimicked human mutations all showed loss of interactions with both of the catalytic subunits. Patient LP94-051 has a comparatively mild neuronal migration phenotype (see Fig. 2 ; Pilz et al., 1999 ) and yet the corresponding mutation in Lis1 abolished PAFAH complex formation as was observed for human mutations that resulted in more severe grades of lissencephaly. Residual binding of the 29 and 30 kDa proteins was detected, however, with our mLis1DN mutant, which is similar although not identical to a mutation found in patient ILS-107. This patient has a LIS1 mutation that causes a partial loss of the N-terminal region of Lis1 and has a relatively mild phenotype (Fogli et al., 1999) . Given the seeming disparity of the results from patients ILS-107 and LP94-051, one would have to say that the question of Lis1 binding strength and severity of phenotype remains open. Examination of LIS1 protein derived from additional patients with mild neuronal migration phenotypes will help allay this incongruity.
Taken together these data show that all human LIS1 mutants examined resulted in either altered or abolished binding of the 29 and 30 kDa subunits suggesting a necessary role for the PAFAH complex for normal brain development. These data do not exclude the possibility that Lis1 interacting with proteins other than the 29 and 30 kDa subunits may be essential for neuronal migration and could contribute to the severity of the lissencephaly phenotype. Indeed, other interacting proteins have been recently identi®ed, including NudC (Morris et al., 1998) and tubulin (Sapir et al., 1998) . We and others are presently investigating potential Lis1 interacting partners and it shall be interesting to repeat this series of binding assays with other Lis1 binding proteins, as they arise, to determine which interactions are fundamental to neuronal migration.
Experimental procedures
Construction of the mutant Lis1 constructs
A plasmid, mLis1pAS2, encoding a fusion protein between mLis1 and the GAL4 DNA binding domain that included an HA epitope tag at the N-terminus of the mLis1 cDNA was created. Site directed mutagenesis was performed using the Stratagene Quickchangee Site-Directed Mutagenesis Kit. Brie¯y, Pfu polymerase was used to extend from synthesised oligonucleotide primers that contained the mutation of interest using 25 ng of the wildtype mLis1pAS2 construct as the template. The thermocycler programme used was 1£ (958C, 30 s); 16£ (958C, 30 s; 558C, 1 min; 688C, 17 min). The mutant DNA products were digested with a restriction endonuclease speci®c for Dam methylated DNA (DpnI) to eliminate the original template before transformation into Stratagene E. coli XL1-Blue supercompetent cells.
The exception to this strategy was the mutation that resulted in the loss of the entire N-terminal region of mLis1. This mutant was generated by amplifying the region of interest from 1 ng of mLis1pAS2. The primers were designed to amplify the mLis1 cDNA excluding the nucleotides encoding for the N-terminal region of the protein. The primers were designed with the appropriate restriction enzyme sites that allowed in-frame, directional cloning into the pAS2 vector. The PCR reaction used 120 mM (®nal concentration) of each nucleotide, 125 ng of each primer, 2.5 U Pfu Turbo DNA polymerase and Pfu DNA polymerase 10X reaction buffer in a volume of 50 ml. The PCR programme used was 1£ (948C, 5 min); 25£ (948C, 30 s; 558C, 30 s; 728C, 30 s); 1£ (728C, 10 min). All clones examined by sequence analysis contained the mutation of interest and no other spurious mutations incorporated by the polymerase. The primers used were as follows; mLis1H149R forward mutant primer: CGA ACT CTC AAG GGC CGT ACA GAC TCT GTA CAG G mLis1H149R reverse mutant primer: CCT GTA CAG AGT CTG TAC GGC CCT TGA GAG TTC G, mLis1D304 forward mutant primer: CTG AAG CAA CAG GAT CTG AGA CTT AAA AAA AGT GGC AAG mLis1D304 reverse mutant primer: CTT GCC ACT TTT TTT AAG TCT CAG ATC CTG TTG CTT CAG, mLis1DN forward primer: GCC ACC ATG GAC GCA TTG AGT GGT CAT AGG mLis1DN reverse Primer: CGG TTG GGA TCC TCA ACG GCA CTC CCA CAC, mLis1D144 forward mutant primer: GAG ACT GGA GAT TTT GAG TGA ACT CTC AAG GGC C mLis1D144 reverse mutant primer: G GCC CTT GAG AGT TCA CTC AAA ATC TCC AGT CTC, mLis1D386 forward mutant primer: CAC TTT GTT ACC TCC TAG GAT TTC CAT AAG ACG GC mLis1D386 reverse mutant primer: GC CGT CTT ATG GAA ATC CTA GGA GGT AAC AAA GTG, mLis1S168P forward mutant primer: C AAG CTT CTG GCT TCC TGT CCA GCA GAT ATG ACG mLis1S168P reverse mutant primer: CGT CAT ATC TGC TGG ACA GGA AGC CAG AAG CTT G, mLis1S152W forward mutant primer: G GGC CAT ACA GAC TGG GTA CAG GAC ATT TCC TTT GAC mLis1S152W reverse mutant primer: GTC AAA GGA AAT GTC CTG TAC CCA GTC TGT ATG GCC C, mLis1V400W forward mutant primer: GTG GTT ACT GGC AGT TGG GAT CAA ACA GTA AAG GTG TGG GAG mLis1V400W reverse mutant primer: CTC CCA CAC CTT TAC TGT TTG ATC CCA ACT GCC AGT AAC CAC.
Yeast two-hybrid assay
The yeast strain used for the yeast two-hybrid assay was PJ69-4A which contains two different nutritional reporter genes (HIS3, ADE2), each driven by a different GAL promoter. This strain was a generous gift of P. James (James et al., 1996) . The cells were transformed using the small scale LiAC transformation procedure as described in the Clontech Matchmaker GAL4 Two-Hybrid User Manual. When assaying for protein-protein interactions the yeast cells transformed with both bait and prey vectors were resuspended in a ®nal volume of 500 ml 1£ TE. One third was then plated out onto each of the following selection plates: selection dropout (SD) -leu, -trp; SD -leu, -trp, -his, SD ±leu, -trp, -ade before being incubated at 308C for 3±5 days. The SD plates were prepared as described in the Clontech Yeast Protocols Handbook using dropout supplements prepared in house from Sigma amino acids and yeast nitrogen base (Difco).
Expression and detection of expressed fusion proteins
Protein was extracted from transformed yeast cells using the Urea/SDS method and reagents as described in the Clontech Yeast Protocols Handbook. Equivalent volumes of each cell lysate (30 ml) were separated via SDS±PAGE using a 10% polyacrylamide gel. The proteins were Western blotted onto PVDF membrane (Machery±Nagel) and the membrane blocked in 5% low-fat milk powder in TBS/ Tween 20 (0.1%) buffer overnight. The membrane was incubated with anti-HA rat monoclonal antibody from Boehringer Mannheim, clone 3F10, at 1:250 in TBS/BSA (5%) for 2 h at R.T., followed by biotin-SP-conjugated Af®niPure rabbit anti-rat IgG (H 1 L) from Jackson Immunoresearch Labs, 1:2000 in 5% low-fat milk in TBS/Tween 20 (0.1%) for 30 min at R.T. and ®nally peroxidase-conju-gated streptavidin from DAKO, at 1:2000 in 5% low-fat milk in TBS/Tween 20 (0.1%) for 30 min at R.T. Washes were typically 3 £ 5 min at R.T. using TBS/ Tween 20 (0.1%). The protein was detected via enhanced chemiluminescence using Amersham Pharmacia ECL reagent. Typically, a 5±10 min exposure to autoradiographic ®lm was required.
GST pull-down assays
The 29 and 30 kDa cDNAs were sub-cloned from pACT2 (Clontech) into the Sma1/EcoR1 sites of pGEX2T (Pharmacia). The resultant GST-fusion proteins were expressed in E. coli XL1-Blue that had been grown to mid-log phase and induced with IPTG (1 mM). Pelleted cells were resuspended in 10 ml of lysis buffer (PBS, total of 300 mM NaCl, 1 mM PMSF, 1 mM EDTA, 1 mM DTT, 0.5% Tween 20, 10 mg/ ml leupeptin and 10 mg/ml aprotinin). Cells were sonicated 6 £ 15 s, on ice and the cell debris pelleted for 10 min, 10 000 rpm, 48C. The supernatant was transferred to a fresh tube and rotated with 1 ml (50% slurry) of pre-swollen and equilibrated glutathione agarose beads (Sigma) for 1 h at 48C. The supernatant was subjected to another incubation with 1 ml of fresh beads overnight at 48C, the two pellets of beads were pooled. The protein concentration was estimated using SDS±PAGE followed by Coomassie staining and then by comparing the fusion protein bands to BSA of known concentrations. mLis1 and the respective mutant cDNAs were subcloned into pBluescriptSK 1 (Stratagene) from pAS2 using EcoR1/ BamH1 sites, to allow for transcription from a T7 promoter. The TNT Quick Coupled Transcription/Translation Kit (Promega) was used, as suggested by supplier, to express 35 S-methionine-labelled mLis1 and mutant mLis1. Each TNT reaction had a ®nal volume of 20 ml, contained 0.4 mg of template, 25 mM KCl and was incubated for 90 min at 308C. S-methionine from Amersham was used.
Radiolabelled mLis1 or mutant mLis1 proteins were incubated with 1 mg of GST or GST-fusion protein and 40 ml of glutathione agarose (50% slurry). The proteins and beads were incubated at 48C for between 2 h until overnight with constant rotation. Following incubation, the mixture was centrifuged and the supernatant removed to a fresh tube. The beads were washed 3£ in wash buffer (50 mM HEPES, 1 mM PMSF, 10 mg/ml leupeptin and 10 mg/ml aprotinin) and resuspended in 30 ml wash buffer with 15 ml 3£ SDS sample buffer. The supernatant from the beads was also prepared for analysis (30 ml 1 15 ml 3£ SDS sample buffer). All samples were boiled brie¯y before being separated on a 10% polyacrylamide gel. The gel was ®xed, incubated for 30 min in Amplify solution (Amersham), dried and exposed to autoradiographic ®lm. An overnight exposure was usually suf®cient to detect radiolabelled protein bands.
